CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 153 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,269,913 | -18.7% | 1,024,139 | -40.3% | 0.03% | -24.4% |
| Q2 2023 | $18,777,257 | +10.0% | 1,714,818 | -12.4% | 0.04% | -4.7% |
| Q1 2023 | $17,065,633 | +4822.0% | 1,957,068 | +3439.1% | 0.04% | +4200.0% |
| Q4 2022 | $346,725 | -39.7% | 55,299 | -31.1% | 0.00% | -75.0% |
| Q2 2019 | $575,000 | -18.7% | 80,264 | +50.7% | 0.00% | -20.0% |
| Q1 2019 | $707,000 | -63.2% | 53,247 | -78.2% | 0.01% | -64.3% |
| Q4 2018 | $1,921,000 | +7904.2% | 244,066 | +1837.0% | 0.01% | – |
| Q3 2015 | $24,000 | -38.5% | 12,600 | -12.0% | 0.00% | – |
| Q2 2015 | $39,000 | – | 14,315 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $11,887,000 | 8.85% |
| Foresite Capital Management IV, LLC | 1,787,094 | $12,939,000 | 2.92% |
| Copernicus Capital Management, LLC | 278,416 | $2,016,000 | 1.92% |
| Sio Capital Management, LLC | 1,159,236 | $8,393,000 | 1.66% |
| ACUTA CAPITAL PARTNERS, LLC | 765,000 | $5,539,000 | 1.50% |
| Avoro Capital Advisors LLC | 10,300,000 | $74,572,000 | 1.06% |
| Boxer Capital, LLC | 4,000,000 | $28,960,000 | 1.00% |
| Vivo Capital, LLC | 2,089,356 | $15,127,000 | 0.87% |
| EAM Global Investors LLC | 284,534 | $2,060,000 | 0.76% |
| Versant Venture Management, LLC | 543,753 | $3,937,000 | 0.72% |